Genetic profiling and individualized prognosis of fracture

Journal of Bone and Mineral Research

Volumn 26, Issue 2, 2011, Pages 414-419

  Tran, Bich Nh ^a   Nguyen, Nguyen D ^a   Nguyen, Vinh X ^b   Center, Jacqueline R ^a,b,c   Eisman, John A ^a,b,c   Nguyen, Tuan V ^a,b,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

FRACTURE; GENETIC PROFILING; INDIVIDUALIZED PROGNOSIS; OSTEOPOROSIS; RECLASSIFICATION ANALYSIS

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; DISEASE CLASSIFICATION; FEMALE; FEMUR NECK; FRACTURE; FRAGILITY FRACTURE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PROGNOSIS; RISK FACTOR;

ABSORPTIOMETRY, PHOTON; AGED; AREA UNDER CURVE; BONE DENSITY; FEMALE; FRACTURE HEALING; FRACTURES, BONE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROGNOSIS; RISK; RISK FACTORS;

EID: 79251480074     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.219     Document Type: Article

References (42)

1. Nguyen ND, Ahlborg HG, Center JR, Eisman JA, Nguyen TV., Residual lifetime risk of fractures in women and men. J Bone Miner Res. 2007; 22: 781-788.
2. Center JR, Bliuc D, Nguyen TV, Eisman JA., Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007; 297: 387-394.
3. Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009; 301: 513-521.
4. Nguyen ND, Eisman JA, Nguyen TV., Anti-hip fracture efficacy of bisphosphonates: a Bayesian analysis of clinical trials. J Bone Miner Res. 2006; 21: 340-349.
5. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007; 357: 1799-1809.
6. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E., FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19: 385-397.
7. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV., Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int. 2007; 18: 1109-1117.
8. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV., Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int. 2008; 19: 1431-1444.
9. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332: 767-773.
10. Deng HW, Chen WM, Recker S, Stegman MR, Li JL, et al. Genetic determination of Colles fracture and differential bone mass in women with and without Colles fracture. J Bone Miner Res. 2000; 15: 1243-1252.
11. Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL., Genetic liability to fractures in the elderly. Arch Intern Med. 2005; 165: 1825-1830.
12. Nguyen TV, Howard GM, Kelly PJ, Eisman JA., Bone mass, lean mass, and fat mass: same genes or same environments ? Am J Epidemiol. 1998; 147: 3-16.
13. Makovey J, Nguyen TV, Naganathan V, Wark JD, Sambrook PN., Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study. J Bone Miner Res. 2007; 22: 1773-1780.
14. Howard GM, Nguyen TV, Harris M, Kelly PJ, Eisman JA., Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res. 1998; 13: 1318-1327.
15. Tokita A, Kelly PJ, Nguyen TV, Qi JC, Morrison NA, et al. Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab. 1994; 78: 1461-1466.
16. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008; 359: 2208-2219.
17. Pharoah PD, Antoniou AC, Easton DF, Ponder BA., Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008; 358: 2796-2803.
18. Ralston SH, de Crombrugghe B., Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006; 20: 2492-2506.
19. Richards JB, Kavvoura FK, Rivadeneira F, Styrkarsdottir U, Estrada K, et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med. 2009; 151: 528-537.
20. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, et al. Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int. 1994; 4: 277-282.
21. Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993; 307: 1111-1115.
22. Simons LA, McCallum J, Simons J, Powell I, Ruys J, et al. The Dubbo study: an Australian prospective community study of the health of elderly. Aust N Z J Med. 1990; 20: 783-789.
23. Nguyen TV, Center JR, Sambrook PN, Eisman JA., Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: the Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol. 2001; 153: 587-595.
24. Nguyen TV, Sambrook PN, Eisman JA., Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss. J Bone Miner Res. 1997; 12: 124-135.
25. Tran BN, Nguyen ND, Center JR, Eisman JA, Nguyen TV., Enhancement of absolute fracture risk prognosis with genetic marker: the collagen I alpha 1 gene. Calcif Tissue Int. 2009; 85: 379-388.
26. Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T, et al. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone. 2005; 36: 599-606.
27. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, et al. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res. 2006; 21: 141-150.
28. Swets JA., Form of empirical ROCs in discrimination and diagnostic tasks: implications for theory and measurement of performance. Psychol Bull. 1986; 99: 181-198.
29. Swets JA., Indices of discrimination or diagnostic accuracy: their ROCs and implied models. Psychol Bull. 1986; 99: 100-117.
30. Swets JA., Measuring the accuracy of diagnostic systems. Science. 1988; 240: 1285-1293.
31. Hanley JA, McNeil BJ., The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143: 29-36.
32. Cook NR., Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008; 54: 17-23.
33. Pencina MJ, DAgostino RB, DAgostino RB Sr, Vasan RS Jr., Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27: 157-172; discussion 207-112.
34. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. 2007.
35. Marshall D, Johnell O, Wedel H., Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996; 312: 1254-1259.
36. Nguyen TV, Center JR, Eisman JA., Femoral neck bone loss predicts fracture risk independent of baseline BMD. J Bone Miner Res. 2005; 20: 1195-1201.
37. Schott AM, Cormier C, Hans D, Favier F, Hausherr E, et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study. Osteoporos Int. 1998; 8: 247-254.
38. Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, et al. Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc. 2004; 52: 1479-1486.
39. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008; 358: 1240-1249.
40. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009; 150: 65-72.
41. Holtzman NA, Marteau TM., Will genetics revolutionize medicine ? N Engl J Med. 2000; 343: 141-144.
42. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008; 359: 2220-2232.